2,534 research outputs found

    Using FTIR-ATR and Chemometric Methods to Detect Sucrose Adulteration in Commercial Honey Samples

    Get PDF
    Fourier transform infrared spectroscopy-attenuated total reflectance (FTIR–ATR) was used to analyze pure and adulterated honey samples. The FTIR spectra was analyzed using principal component analysis (PCA) and partial least squares (PLS) regression analysis to determine if these methods could differentiate between pure, commercial, and sucrose-adulterated honey samples. PCA showed a clear distinction between pure and adulterated honey samples. Commercial honey samples showed clustering around the unadulterated samples. PLS regression analysis correctly identified 81.8% of the standards and samples used in the PCA analysis. The five commercial samples were tested and shown to have a concentration of less than 3% adulterant, which is likely due to differences in sucrose concentration between batches from different locations and bee types. PCA and PLS methods provide a quick and easy analysis of honey samples

    Listening to limericks: a pupillometry investigation of perceivers’ expectancy

    Get PDF
    What features of a poem make it captivating, and which cognitive mechanisms are sensitive to these features? We addressed these questions experimentally by measuring pupillary responses of 40 participants who listened to a series of Limericks. The Limericks ended with either a semantic, syntactic, rhyme or metric violation. Compared to a control condition without violations, only the rhyme violation condition induced a reliable pupillary response. An anomaly-rating study on the same stimuli showed that all violations were reliably detectable relative to the control condition, but the anomaly induced by rhyme violations was perceived as most severe. Together, our data suggest that rhyme violations in Limericks may induce an emotional response beyond mere anomaly detection

    Enhancing road verges to aid pollinator conservation: A review

    Get PDF
    Road verges provide habitats that have considerable potential as a tool for pollinator conservation, especially given the significant area of land that they collectively cover. Growing societal interest in managing road verges for pollinators suggests an immediate need for evidence-based management guidance. We used a formal, global literature review to assess evidence for the benefits of road verges for pollinators (as habitats and corridors), the potential negative impacts of roads on pollinators (vehicle-pollinator collisions, pollution, barriers to movement) and how to enhance road verges for pollinators through management. We identified, reviewed and synthesised 140 relevant studies. Overall, the literature review demonstrated that: (i) road verges are often hotspots of flowers and pollinators (well established), (ii) traffic and road pollution can cause mortality and other negative impacts on pollinators (well established), but available evidence suggests that the benefits of road verges to pollinators far outweigh the costs (established but incomplete), and (iii) road verges can be enhanced for pollinators through strategic management (well established). Future research should address the lack of holistic and large-scale understanding of the net effects of road verges on pollinators. We provide management recommendations for enhancing both individual road verges for pollinators (e.g. optimised mowing regimes) and entire road networks (e.g. prioritising enhancement of verges with the greatest capacity to benefit pollinators), and highlight three of the most strongly supported recommendations: (i) creating high quality habitats on new and existing road verges, (ii) reducing mowing frequency to 0–2 cuts/year and (iii) reducing impacts of street lighting

    The effects of estradiol-17β on the sex reversal, survival, and growth of green sunfish Lepomis cyanellus

    Get PDF
    The feminization of green sunfish Lepomis cyanellus could expand their utility as a game fish or aquacultured species by preventing overcrowding and precocious reproduction in stocked systems. Feminization of green sunfish could also help elucidate information on their sex determination system. We report the feminization of green sunfish cohorts via oral administration of estradiol-17β (E2) during early development. A low-dose (100 E2 mg per kg of diet) and a high-dose (150 E2 mg per kg of diet) experimental E2 treatment were fed to juvenile green sunfish from 30 to 90 days post-hatch. Fish were subsequently evaluated for any treatment effect on gonadal development, survival, and growth. Both E2 treatments resulted in 100% feminization, with no morphological or histological differences detected between E2 treated ovaries and those from a control group. The control group was composed mostly of males (82.61%). Overall, there was no effect of E2 on survival (P = 0.310) and growth rate data suggested no statistical differences (P = 0.0805). However, the growth rate of the high-dose group increased slightly higher after the treatment ended than the other treatments (P = 0.042), suggesting that E2 might suppress growth in green sunfish. In addition, the control group did not exhibit a higher survival rate after the treatment period ended (P = 0.266), whereas both E2 treated groups did (P = 0.0003–0.0050). We found that the low dose, 100 E2 mg per kg of diet, was sufficient for fully feminizing green sunfish if administered during development from 30 to 90 days post-hatch and E2 dosages may result in deleterious effects on green sunfish’s health and growth

    Renal safety of zoledronic acid with thalidomide in patients with myeloma: a pharmacokinetic and safety sub-study

    Get PDF
    BACKGROUND: Cases of impaired renal function have been reported in patients who had been treated with both zoledronic acid and thalidomide for myeloma. Hence, we conducted a safety study of zoledronic acid and thalidomide in myeloma patients participating in a trial of maintenance therapy. METHODS: Twenty-four patients who were enrolled in a large randomized trial of thalidomide vs no thalidomide maintenance therapy for myeloma, in which all patients also received zoledronic acid, were recruited to a pharmacokinetic and renal safety sub-study, and followed for up to 16 months. RESULTS: No significant differences by Wilcoxon rank-sum statistic were found in zoledronic acid pharmacokinetics or renal safety for up to 16 months in patients randomized to thalidomide or not. CONCLUSION: In myeloma patients receiving maintenance therapy, the combination of zoledronic acid and thalidomide appears to confer no additional renal safety risks over zoledronic acid alone

    New Multiwavelength Observations of PKS 2155-304 and Implications for the Coordinated Variability Patterns of Blazars

    Full text link
    The TeV blazar PKS 2155--304 was the subject of an intensive 2 week optical and near-infrared observing campaign in 2004 August with the CTIO 0.9m telescope. During this time, simultaneous X-ray data from RXTE were also obtained. We compare the results of our observations to the results from two previous simultaneous multiwavelength campaigns on PKS 2155-304. We conclude that the correlation between the X-ray and UV/optical variability is strongest and the time lag is shortest (only a few hours) when the object is brightest. As the object becomes fainter, the correlations are weaker and the lags longer, increasing to a few days. Based on the results of four campaigns, we find evidence for a linear relationship between the mean optical brightness and lag time of X-ray and UV/optical events. Furthermore, we assert that this behavior, along with the different multiwavelength flare lag times across different flux states is consistent with a highly relativistic shock propagating down the jet producing the flares observed during a high state. In a quiescent state, the variability is likely to be due to a number of factors including both the jet and contributions outside of the jet, such as the accretion disk.Comment: 23 pages, 8 figures, to be published in the Astrophysical Journal, volume 67

    Preclinical development of a bispecific TNFα/IL-23 neutralising domain antibody as a novel oral treatment for inflammatory bowel disease.

    Get PDF
    Anti-TNFα and anti-IL-23 antibodies are highly effective therapies for Crohn's disease or ulcerative colitis in a proportion of patients. V56B2 is a novel bispecific domain antibody in which a llama-derived IL-23p19-specific domain antibody, humanised and engineered for intestinal protease resistance, V900, was combined with a previously-described TNFα-specific domain antibody, V565. V56B2 contains a central protease-labile linker to create a single molecule for oral administration. Incubation of V56B2 with trypsin or human faecal supernatant resulted in a complete separation of the V565 and V900 monomers without loss of neutralising potency. Following oral administration of V900 and V565 in mice, high levels of each domain antibody were detected in the faeces, demonstrating stability in the intestinal milieu. In ex vivo cultures of colonic biopsies from IBD patients, treatment with V565 or V900 inhibited tissue phosphoprotein levels and with a combination of the two, inhibition was even greater. These results support further development of V56B2 as an oral therapy for IBD with improved safety and efficacy in a greater proportion of patients as well as greater convenience for patients compared with traditional monoclonal antibody therapies
    corecore